1. Home
  2. NSPR vs KPLT Comparison

NSPR vs KPLT Comparison

Compare NSPR & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.76

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Logo Katapult Holdings Inc.

KPLT

Katapult Holdings Inc.

N/A

Current Price

$9.19

Market Cap

39.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
KPLT
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
39.2M
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
NSPR
KPLT
Price
$0.76
$9.19
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$4.00
$10.00
AVG Volume (30 Days)
48.1K
102.2K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.15
EPS
N/A
N/A
Revenue
$2,310,000.00
$291,761,000.00
Revenue This Year
$57.98
$18.62
Revenue Next Year
$95.41
$15.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.03
52 Week Low
$0.63
$5.30
52 Week High
$2.57
$22.00

Technical Indicators

Market Signals
Indicator
NSPR
KPLT
Relative Strength Index (RSI) 42.04 69.88
Support Level $0.66 $6.05
Resistance Level $1.03 $9.21
Average True Range (ATR) 0.06 0.70
MACD -0.02 0.31
Stochastic Oscillator 9.78 90.56

Price Performance

Historical Comparison
NSPR
KPLT

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: